Overview of MicroRNA (miRNA) Research and Common Regulatory Tools
Overview of MicroRNA (miRNA) Research and Common Regulatory Tools
MicroRNA (miRNA) is a class of endogenous non-coding small RNA with a length of approximately 20–24 nt. It mainly regulates gene expression by recognizing target mRNAs. miRNA research is commonly used to analyze post-transcriptional regulatory networks, disease mechanisms, cell fate regulation and drug response processes, and is an important research direction in molecular biology, oncology, developmental biology and regenerative medicine.
Keywords: MicroRNA; miRNA; non-coding RNA; post-transcriptional regulation; miRNA mimic; miRNA inhibitor; miRNA agomir; miRNA antagomir; target gene validation
1 Basic Concepts of miRNA
1.1 Molecular Characteristics
(1) Length and structure
miRNA is a class of short non-coding RNA. Mature miRNA is usually approximately 20–24 nt in length. It does not encode proteins, but recognizes target mRNAs through sequence complementarity, thereby affecting target gene expression levels. Because miRNA sequences are short, their regulatory effects highly depend on mature strand sequence, seed region pairing characteristics and the binding-site environment of target mRNAs.
(2) Expression specificity
miRNAs show clear specificity in cell type, tissue type and developmental stage. Different tissues have different miRNA expression profiles, and the same miRNA may also change dynamically under different cellular states. Conditions such as tumors, inflammation, hypoxia, differentiation, senescence and drug stimulation can all alter miRNA expression. Therefore, miRNAs are often used to characterize cellular states and disease progression.
(3) Broad regulatory scope
One miRNA can regulate multiple target genes, and one target gene can also be jointly regulated by multiple miRNAs. Therefore, miRNAs are not simple single-gene switches, but important nodes in gene regulatory networks. Their functional outcomes often appear as changes in a group of genes, altered pathway activity and remodeled cellular phenotypes.
(4) Context-dependent function
The same miRNA may show different functions in different cellular or disease contexts. For example, a miRNA may act as a tumor suppressor in some tumors, but participate in tumor promotion in another tumor type or specific microenvironment. When evaluating miRNA function, cell origin, target gene profile, expression level and pathway context should be analyzed comprehensively.
1.2 Biogenesis Process
(1) Formation of primary transcripts
miRNA genes are usually transcribed by RNA polymerase to form primary miRNAs. Primary miRNAs have hairpin-like structures and serve as precursor forms for subsequent maturation. Some miRNAs are located in independent transcriptional units, while others are located in intronic regions of protein-coding genes, and their expression may be associated with host genes.
(2) Nuclear processing
Primary miRNAs are processed in the nucleus by Drosha and related complexes to form precursor miRNAs. This process determines the early efficiency of mature miRNA strand generation and may also be regulated by cell differentiation status, stress signals and RNA-binding proteins.
(3) Cytoplasmic maturation
Precursor miRNAs are processed by Dicer in the cytoplasm to form miRNA duplexes. One strand becomes the functional strand and is loaded into the RNA-induced silencing complex, while the other strand is usually degraded, although it may also be retained and function in certain cellular contexts. Many miRNAs have both 5p and 3p mature strands, and their target gene profiles may differ significantly.
(4) RISC loading
After the mature miRNA functional strand enters the RNA-induced silencing complex, it can act as a guide strand to recognize target mRNAs. RISC loading efficiency, functional strand selection and Argonaute protein binding status affect the actual functional strength of miRNA. Detecting total miRNA abundance alone cannot fully reflect its activity level.
1.3 Modes of Target Gene Regulation
(1) Seed sequence recognition
Recognition of target mRNAs by miRNAs mainly depends on the seed sequence at positions 2–8 from the 5′ end. When the seed sequence is complementary to the 3′UTR region of the target mRNA, effective regulation is more likely to occur. In addition to the seed region, adjacent sequences, target-site structure, site number and conservation also affect regulatory efficiency.
(2) mRNA degradation
After a miRNA binds to a target mRNA, it can promote target mRNA degradation, causing a decrease in target gene mRNA level. Such changes can usually be evaluated by RT-qPCR, RNA-seq or transcript-level assays.
(3) Translational repression
For some miRNAs, the main effect on target genes occurs at the translational level. In this case, mRNA levels may not change significantly, while target protein expression decreases. Therefore, Western blot, immunofluorescence, flow cytometry and proteomic analysis are important for miRNA functional studies.
(4) Pathway remodeling
Coordinated regulation of multiple target genes by miRNAs may cause pathway-level changes. If multiple target genes are concentrated in pathways related to cell cycle, apoptosis, inflammation, metabolism, migration or differentiation, pathway readouts usually better reflect the biological effects of miRNAs than a single target gene.
2 Major Directions in miRNA Research
2.1 Disease Mechanism Research
(1) Tumorigenesis and tumor progression
miRNAs can affect cell proliferation, apoptosis, migration, invasion, epithelial-mesenchymal transition, angiogenesis and drug tolerance. Some miRNAs have oncogenic effects, while others have tumor-suppressive effects, depending on the target gene profile and cellular context. In tumor research, mimic, inhibitor, agomir or antagomir tools are often used to regulate miRNA activity and validate its role in malignant phenotypes.
(2) Inflammation and immune regulation
miRNAs can regulate inflammatory factor expression, immune cell activation, macrophage polarization, dendritic cell maturation and T-cell differentiation. Under inflammatory stimulation, changes in specific miRNA expression are often associated with NF-kB, JAK/STAT, MAPK, TLR and interferon-related pathways. Such studies need to strictly distinguish miRNA-specific effects from background effects caused by nucleic acid delivery or the stimulus itself.
(3) Metabolic and cardiovascular diseases
miRNAs participate in lipid metabolism, glucose metabolism, vascular endothelial function, myocardial hypertrophy, myocardial fibrosis and ischemia-reperfusion injury. Related studies often focus on miRNA regulation of metabolic enzymes, transcription factors, ion channels, cellular stress pathways and extracellular matrix remodeling.
(4) Nervous system diseases
Neural development, synaptic plasticity, neuroinflammation and neurodegenerative disorders are all associated with miRNA regulation. Because neural cells are sensitive to transfection and delivery conditions, such studies require particular attention to delivery efficiency, cytotoxicity, detection time windows and neural functional indicators.
2.2 Development and Differentiation Research
(1) Stem cell fate regulation
miRNAs can influence stem cell self-renewal and lineage differentiation. Some miRNAs participate in pluripotency maintenance, while others promote differentiation toward neural, muscle, epithelial, hepatocyte-like, cardiomyocyte-like or immune cell lineages. By regulating miRNA activity, researchers can analyze its regulatory nodes in cell fate transitions.
(2) Tissue development regulation
Specific miRNA expression profiles are present at different developmental stages. By interfering with miRNA expression, researchers can analyze their roles in organ formation, tissue maturation and cell lineage establishment. Such studies usually need to combine time-series expression analysis, lineage marker detection and functional maturation indicators.
(3) Regeneration and repair
After tissue injury, miRNAs may participate in cell migration, inflammation resolution, fibrosis, angiogenesis and regenerative repair. Regulating related miRNAs helps explore tissue repair mechanisms and can also be used to evaluate the potential value of miRNA-targeted intervention in injury repair.
2.3 Target Gene and Pathway Research
(1) Candidate target gene screening
Target gene prediction is usually based on seed sequence complementarity, site conservation, binding energy and transcript structure. Prediction results can only provide candidate ranges and cannot replace experimental validation. When screening target genes, expression profile changes, protein-level changes, pathway function and research phenotype should be evaluated comprehensively.
(2) Direct targeting validation
Direct targeting relationships usually need to be validated by combining dual-luciferase reporter assays, target gene mRNA detection, protein detection and mutant site validation. Expression correlation alone is insufficient to prove direct regulation, because target gene changes may also result from indirect pathway effects.
(3) Pathway network analysis
miRNAs often act on multiple target genes simultaneously, so pathway-level analysis is more complete than single-target interpretation. If multiple target genes are concentrated in the same functional pathway, rescue experiments can further confirm the main functional nodes.
(4) Multi-omics integration
miRNA research can be combined with miRNA-seq, mRNA-seq, proteomics, single-cell sequencing and epigenomic data. By integrating miRNA expression changes, inverse changes in target gene expression and pathway enrichment results, the reliability of candidate regulatory axis screening can be improved.
3 miRNA Functional Enhancement Tools
3.1 miRNA Mimic
(1) Functional characteristics
A miRNA mimic is an artificially synthesized small RNA molecule, usually in a double-stranded structure, used to simulate the function of endogenous mature miRNA. After transfection into cells, its functional strand can participate in loading into the RNA-induced silencing complex and suppress target gene expression.
(2) Applicable scenarios
A miRNA mimic is suitable for studying gain-of-function effects of low-expression miRNAs. If a miRNA is downregulated under disease or stimulation conditions, a mimic can be used to supplement its function and observe changes in target genes and cellular phenotypes.
(3) Experimental focus
Mimic experiments should include negative control mimic, transfection reagent control and necessary positive controls. Detection should include target mRNA, target protein and cellular phenotypes, avoiding functional judgment based on only one indicator.
(4) Result interpretation
A mimic is an exogenous functional enhancement tool, and miRNA activity after treatment may exceed the endogenous physiological level. Therefore, dose optimization is critical. If the concentration is too high, the target gene spectrum may expand or nonspecific silencing effects may occur.
3.2 miRNA Agomir
(1) Tool positioning
A miRNA agomir is a chemically modified miRNA functional enhancement tool with stronger stability. Compared with ordinary mimics, agomirs are more suitable for long-term experiments, tissue-level studies and animal model applications.
(2) Application advantages
Agomirs often improve in vivo action time and tissue exposure through stability modifications or delivery-related modifications. They can be used to simulate high miRNA expression and analyze the effects of target gene silencing on tissue pathology and physiological function.
(3) Control points
Agomir experiments should focus on dose, administration route, tissue distribution, duration of action and safety. In in vivo experiments, detecting increased miRNA levels alone is not sufficient; target gene downregulation and phenotypic changes also need to be confirmed.
(4) Applicable boundaries
Agomirs are more suitable for studies in which the target miRNA is lowly expressed, functionally insufficient or requires in vivo supplementation. If the target miRNA is already significantly elevated, further enhancement may cause supraphysiological effects and affect mechanistic interpretation.
3.3 miRNA Expression Vector
(1) Expression mode
A miRNA expression vector usually produces pri-miRNA or pre-miRNA-like precursors through intracellular transcription, which are then processed by the endogenous miRNA biogenesis machinery into mature miRNAs, and can be used to establish stable cell models. Compared with synthetic nucleic acids, expression vectors are more suitable for long-term expression studies.
(2) Applicable scope
This tool is suitable for lentiviral, plasmid or stable transfection systems and is commonly used in long-term culture, cell differentiation and animal transplantation models. If a study requires sustained elevation of a specific miRNA level, an expression vector can be prioritized.
(3) Limiting factors
Expression vectors depend on transcription, processing and intracellular maturation. The final functional level may be affected by promoter strength, copy number, cell status and processing efficiency. Mature miRNA level and target gene response should be confirmed in experiments.
(4) Differences from synthetic nucleic acids
Synthetic nucleic acid tools are more convenient for dose control and short-term treatment, while expression vectors are more suitable for sustained expression and stable model construction. The miRNA level, duration and cellular adaptation induced by the two types of tools differ, and results may not be completely consistent.
4 miRNA Functional Inhibition Tools
4.1 miRNA Inhibitor
(1) Functional characteristics
A miRNA inhibitor is an antisense nucleic acid tool designed against mature miRNA. It can bind complementarily to the target miRNA and block its regulation of target mRNAs. It is suitable for constructing miRNA functional reduction models.
(2) Applicable scenarios
Inhibitors are more suitable for cells with relatively high basal expression of the target miRNA or models in which the target miRNA is upregulated after stimulation. If target miRNA expression is extremely low, inhibitor treatment often produces no obvious result.
(3) Validation focus
The effectiveness of a miRNA inhibitor should not be evaluated only by the apparent miRNA level, but also by whether target genes are derepressed. An increase in target mRNA or target protein is an important basis for judging whether functional inhibition is established.
(4) Advantages in in vitro experiments
Inhibitors are mostly used for short-term in vitro functional validation and are suitable for rapidly determining whether a target miRNA participates in a specific cellular phenotype. Key control points include transfection efficiency, cytotoxicity, negative control background and detection time window.
4.2 miRNA Antagomir
(1) Tool positioning
A miRNA antagomir is a miRNA antagonist with stronger stability and usually chemical modifications. It has the same functional direction as an inhibitor, but places greater emphasis on long-term inhibition, in vivo stability and compatibility with animal experiments.
(2) Application characteristics
Antagomirs can be used to inhibit specific miRNAs in vivo and observe target gene recovery, tissue phenotype changes and disease progression changes. Research focuses include delivery efficiency, tissue distribution, duration of action and nonspecific effects.
(3) Design focus
Antagomir design usually needs to consider mature strand selection, species matching, chemical modification and dose window. High concentration or overly strong modification may cause cytotoxicity, immune stimulation or nonspecific binding.
(4) Distinction from inhibitor
Inhibitors are more oriented toward short-term inhibition at the cellular level, while antagomirs are more oriented toward stable modification and long-term antagonism in vivo. Selection should be based on experimental duration, delivery method, research object and whether animal model intervention is required.
4.3 miRNA Sponge and Tough Decoy
(1) miRNA sponge
A miRNA sponge is a transcript containing multiple miRNA binding sites. It can competitively absorb target miRNAs and reduce their regulation of natural target mRNAs. This tool is suitable for long-term inhibition or simultaneous inhibition of a group of homologous miRNAs.
(2) Tough decoy
A tough decoy is a structurally optimized miRNA capture tool that usually has strong miRNA binding and inhibitory capacity. It can be continuously produced through an expression vector and is suitable for stable cell lines or long-term in vivo studies.
(3) Application differences
Inhibitors and antagomirs are more suitable for short- or medium-term nucleic acid intervention; sponges and tough decoys are more suitable for long-term expression-based inhibition. If the study requires sustained weakening of a miRNA family, sponge-type tools have advantages.
(4) Specificity control
The binding-site design of sponges and tough decoys affects the inhibition range. If the binding sites share the seed region with multiple family members, multiple miRNAs may be absorbed simultaneously. The experiment should clearly define whether the research target is a single miRNA or a miRNA family.
5 miRNA Targeting Validation Tools
5.1 Dual-Luciferase Reporter System
(1) Basic principle
After the candidate target gene 3′UTR is cloned into a luciferase reporter vector, direct regulation of this region by miRNA can be detected. If a miRNA mimic or agomir reduces reporter signal, while an inhibitor or antagomir restores reporter signal, this supports a targeting relationship.
(2) Mutation validation
To confirm the key role of the seed sequence binding site, a mutant 3′UTR usually needs to be constructed. If the inhibitory effect of miRNA on reporter signal is weakened or abolished after mutation, this strengthens direct targeting evidence.
(3) Interpretation limitations
The reporter system is a simplified model and cannot fully represent the endogenous transcript environment. mRNA structure, RNA-binding proteins, transcript isoforms and cellular status can all affect endogenous target gene regulation. Therefore, endogenous mRNA and protein detection are still required.
(4) Combined validation
Dual-luciferase reporter assays are more suitable for proving direct binding relationships, but should not be used alone as complete mechanistic evidence. A rigorous strategy should combine miRNA regulatory tools, wild-type and mutant 3′UTRs, target gene expression detection and functional rescue experiments.
5.2 Rescue Experiments
(1) Target gene rescue
If a miRNA mimic or agomir downregulates a target gene and causes phenotypic changes, a target gene expression vector without the miRNA binding site can be reintroduced. If the phenotype is restored after rescue, this supports that the target gene is located in the miRNA-mediated regulatory chain.
(2) Secondary target gene knockdown
If an inhibitor or antagomir causes a target gene to increase and induces phenotypic changes, siRNA can be further used to knock down that target gene. If the phenotype is reversed, this indicates that the target gene participates in the functional effect after miRNA inhibition.
(3) Multi-target validation
miRNAs usually regulate multiple target genes, and a single rescue experiment may not fully explain the phenotype. For complex phenotypes, multiple candidate targets should be detected and pathway analysis should be combined to determine the main regulatory network.
(4) Pathway rescue
When multiple target genes are concentrated in the same pathway, pathway inhibitors, agonists or downstream node overexpression can be used for rescue analysis. Pathway-level rescue helps determine whether the major functional output of the miRNA depends on a specific signaling axis.
5.3 Endogenous Target Gene Validation
(1) Combined mRNA and protein detection
If target genes decrease after miRNA functional enhancement, or increase after miRNA functional inhibition, both mRNA and protein levels should be detected. mRNA changes alone are insufficient to indicate a complete functional result, and protein-level changes are usually closer to phenotypic output.
(2) Time-course analysis
miRNA-mediated changes in mRNA, protein and phenotype occur with time differences. Target mRNA changes usually occur earlier, protein changes are relatively delayed, and cellular phenotype changes may take longer. Time-course analysis helps establish the regulatory sequence.
(3) Confirmation of expression background
Candidate target genes must have sufficient expression in the current cell or tissue. If the basal level of the target gene is extremely low, obvious regulatory results may be difficult to observe even if predicted binding sites exist.
6 Comparison of Common Regulatory Tools
Tool Type | Direction of Action | Main Use | Applicable Scenario | Key Notes |
miRNA mimic | Enhances miRNA function | Simulates high miRNA activity | Cell-level gain-of-function experiments | Transfection concentration and off-target effects should be controlled |
miRNA agomir | Long-term enhancement of miRNA function | In vivo or long-cycle functional supplementation | Animal models, tissue-level studies | Modifications, delivery and tissue distribution should be considered |
miRNA expression vector | Continuously increases miRNA expression | Stable cell model construction | Long-term culture, lentiviral systems | Mature miRNA level should be validated |
miRNA inhibitor | Inhibits miRNA function | Loss-of-function validation | Short-term in vitro experiments | Target miRNA should have relatively high basal expression |
miRNA antagomir | Long-term inhibition of miRNA function | In vivo antagonism and tissue intervention | Animal models, long-term inhibition | Chemical modifications and nonspecific effects should be considered |
miRNA sponge | Competitively absorbs miRNA | Long-term inhibition of miRNA or family members | Stable expression systems | Number and specificity of binding sites should be evaluated |
Tough decoy | Efficiently captures miRNA | Enhanced long-term inhibition | Long-term in vivo studies, viral vectors | Expression level and off-target risk should be controlled |
Dual-luciferase system | Validates targeting relationship | Determines direct 3′UTR regulation | Target gene validation | Wild-type and mutant vectors should be included |
Rescue experiment | Validates functional chain | Determines whether the target gene mediates phenotype | Mechanistic validation | Appropriate rescue or secondary intervention strategy should be selected |
7 Reagent Selection for miRNA Functional Regulation and Targeting Validation
Product Category | Cat. No. | Product Name | Applicable Scenario | Selection Notes |
Mimic negative control | MicroRNA Mimic Negative Control | miRNA mimic functional enhancement experiment | Used to exclude double-stranded RNA transfection and nonspecific sequence effects | |
Mimic representative product | hsa-let-7g-5p mimic | let-7 family functional enhancement research | Suitable for let-7g-5p-related target gene regulation and cellular phenotype validation | |
Mimic representative product | hsa-let-7i-3p mimic | let-7 family functional enhancement research | Suitable for comparing functional differences among different mature strands of let-7 | |
Mimic representative product | hsa-let-7i-5p mimic | let-7 family functional enhancement research | Suitable for let-7i-5p-mediated target gene silencing research | |
Mimic representative product | hsa-miR-1-3p mimic | miR-1-3p functional enhancement research | Suitable for mechanism analysis related to myogenic processes, tumors and cell proliferation | |
Mimic representative product | hsa-miR-100-5p mimic | miR-100-5p functional enhancement research | Suitable for target gene silencing, proliferation regulation and pathway function validation | |
Mimic representative product | hsa-miR-101-2-5p mimic | miR-101-2-5p functional enhancement research | Suitable for target gene regulation studies related to the miR-101 family | |
Mimic representative product | hsa-miR-101-3p mimic | miR-101-3p functional enhancement research | Suitable for epigenetic regulation and tumor mechanism analysis related to miR-101-3p | |
Mimic representative product | hsa-miR-101-5p mimic | miR-101-5p functional enhancement research | Suitable for 5p mature strand functional enhancement and target gene validation | |
Agomir negative control | MicroRNA Agomir Negative Control | miRNA agomir functional enhancement experiment | Used to exclude background effects caused by modified nucleic acids and delivery systems | |
Agomir representative product | hsa-let-7g-5p agomir | let-7g-5p long-term functional enhancement research | Suitable for miRNA functional supplementation in cell or animal models | |
Agomir representative product | hsa-let-7i-3p agomir | let-7i-3p long-term functional enhancement research | Suitable for let-7i-3p-related target gene silencing and phenotype analysis | |
Agomir representative product | hsa-let-7i-5p agomir | let-7i-5p long-term functional enhancement research | Suitable for let-7 family functional supplementation and pathway validation | |
Agomir representative product | hsa-miR-1-3p agomir | miR-1-3p long-term functional enhancement research | Suitable for functional experiments requiring higher stability or longer treatment periods | |
Agomir representative product | hsa-miR-100-5p agomir | miR-100-5p functional enhancement research | Suitable for validation of target gene silencing and pathway inhibition effects | |
Agomir representative product | hsa-miR-101-2-5p agomir | miR-101-2-5p functional enhancement research | Suitable for functional supplementation studies related to the miR-101 family | |
Agomir representative product | hsa-miR-101-3p agomir | miR-101-3p functional enhancement research | Suitable for long-term target gene silencing and cellular phenotype validation | |
Agomir representative product | hsa-miR-101-5p agomir | miR-101-5p functional enhancement research | Suitable for in vitro and in vivo functional enhancement experiments on the 5p mature strand | |
Inhibitor negative control | MicroRNA Inhibitor Negative Control | miRNA inhibitor functional inhibition experiment | Used to evaluate nonspecific nucleic acid effects in miRNA inhibition experiments | |
Inhibitor representative product | hsa-miR-106b-3p inhibitor | miR-106b-3p functional inhibition research | Suitable for target gene derepression and loss-of-function validation | |
Inhibitor representative product | hsa-miR-106b-5p inhibitor | miR-106b-5p functional inhibition research | Suitable for comparing the functions of different mature strands of miR-106b | |
Inhibitor representative product | hsa-miR-107 inhibitor | miR-107 functional inhibition research | Suitable for miRNA regulation studies related to metabolism, proliferation and stress | |
Inhibitor representative product | hsa-miR-10a-3p inhibitor | miR-10a-3p functional inhibition research | Suitable for target gene derepression analysis of miR-10a-3p | |
Inhibitor representative product | hsa-miR-10a-5p inhibitor | miR-10a-5p functional inhibition research | Suitable for mechanism analysis related to migration, inflammation or differentiation | |
Inhibitor representative product | hsa-miR-10b-3p inhibitor | miR-10b-3p functional inhibition research | Suitable for cellular phenotype validation related to miR-10b-3p | |
Inhibitor representative product | hsa-miR-10b-5p inhibitor | miR-10b-5p functional inhibition research | Suitable for migration, invasion and target gene recovery studies related to miR-10b-5p | |
Inhibitor representative product | hsa-miR-11181-3p inhibitor | miR-11181-3p functional inhibition research | Suitable for specific miRNA loss-of-function and candidate target gene analysis | |
Antagomir negative control | MicroRNA Antagomir Negative Control | miRNA antagomir functional antagonism experiment | Suitable for negative control setup in long-term inhibition or in vivo antagonism experiments | |
Fluorescently labeled antagomir control | Cy3 MicroRNA Antagomir Negative Control | Antagomir transfection tracing | Suitable for observing cellular uptake, delivery efficiency and transfection distribution | |
Antagomir representative product | hsa-miR-10398-3p antagomir | miR-10398-3p functional antagonism research | Suitable for target gene derepression and long-term inhibition experiments | |
Antagomir representative product | hsa-miR-10398-5p antagomir | miR-10398-5p functional antagonism research | Suitable for 5p mature strand antagonism and target gene recovery validation | |
Antagomir representative product | hsa-miR-10399-3p antagomir | miR-10399-3p functional antagonism research | Suitable for specific miRNA loss-of-function models | |
Antagomir representative product | hsa-miR-10399-5p antagomir | miR-10399-5p functional antagonism research | Suitable for long-term miRNA inhibition and phenotype reversal analysis | |
Antagomir representative product | hsa-miR-103a-1-5p antagomir | miR-103a-1-5p functional antagonism research | Suitable for target gene derepression related to miR-103a | |
Antagomir representative product | hsa-miR-103a-2-5p antagomir | miR-103a-2-5p functional antagonism research | Suitable for functional comparison of miR-103a mature strands | |
Antagomir representative product | hsa-miR-103a-3p antagomir | miR-103a-3p functional antagonism research | Suitable for miRNA antagonism experiments with high-purity requirements | |
Antagomir representative product | hsa-miR-105-5p antagomir | miR-105-5p functional antagonism research | Suitable for target gene recovery, migration-related or barrier-related mechanism studies | |
Targeting validation tool | MicroRNA Studies Luciferase Plasmid | miRNA target gene validation | Suitable for dual-luciferase reporter assays to analyze direct regulation between miRNA and target gene 3′UTR | |
miR-21 inhibition tool | microRNA-21-IN-1 | miR-21 functional inhibition research | Suitable for target gene derepression and disease mechanism research related to miR-21 | |
miR-21 inhibition tool | microRNA-21-IN-3 | miR-21 functional inhibition research | Can serve as a representative small-molecule tool for miR-21 inhibition |
8 miRNA Experimental Workflow Recommendations
8.1 Preliminary Screening
(1) Candidate miRNA identification
Candidate miRNAs can come from miRNA-seq, microarray, qPCR screening, database analysis or previous research evidence. After screening, their expression direction, change magnitude and reproducibility in the research model should be confirmed first.
(2) Preliminary target gene screening
Candidate target genes should be screened by combining prediction results, inverse expression changes, pathway relevance and literature evidence. For functional studies, target genes directly related to the phenotype should be prioritized.
(3) Model feasibility assessment
Before formal intervention, it should be confirmed that both the target miRNA and candidate target genes are detectable in the model. If the basal level of the miRNA or target gene is too low, the interpretability of subsequent regulatory experiments will decrease significantly.
8.2 Establishment of Intervention Conditions
(1) Tool type selection
Tools should be selected according to the expression direction of the miRNA and the research objective. When the target miRNA is downregulated, mimic or agomir can be considered. When the target miRNA is upregulated, inhibitor or antagomir can be considered. For long-term stable studies, expression vectors, sponges or tough decoys can be considered.
(2) Dose and time optimization
Different tools have different action speeds and durations. Cell experiments should include dose gradients and time gradients. Animal experiments should be optimized based on administration frequency, tissue distribution and sampling time.
(3) Control system establishment
The control system should at least include negative control, delivery control and untreated control. If mechanistic validation is involved, bidirectional regulation, target gene rescue or pathway intervention controls should also be added.
8.3 Mechanistic Validation
(1) Molecular chain validation
A relatively complete molecular chain should include miRNA changes, direct target gene changes, pathway indicator changes and phenotypic changes. Results from functional enhancement and functional inhibition tools should support each other directionally.
(2) Direct targeting validation
Wild-type and mutant 3′UTR reporter systems can be used to determine whether a miRNA directly acts on the target gene binding site. If the regulatory effect disappears after mutation, this indicates that the site has functional significance.
(3) Functional rescue validation
Rescue experiments are used to confirm whether target genes mediate miRNA-induced phenotypic changes. For complex pathways, multi-target detection and pathway rescue strategies can improve mechanistic interpretation.
The core of miRNA research is to analyze the regulatory relationship between small RNAs, target gene networks and cellular function. Rational selection of tools such as mimic, agomir, inhibitor, antagomir and sponge, combined with target gene validation, control systems and phenotypic analysis, can improve the accuracy and mechanistic interpretability of miRNA functional studies.